
A team led by Costas Lyssiotis, Ph.D. in the Rogel Cancer Center and Department of Molecular & Integrative Physiology, made the bracket for a study that shows why pancreatic cancer cells stubbornly resist treatment with a common chemotherapy drug. It could pave the way to better treatment options.
A joint Engineering/Rogel Cancer Center team led by Eusik Yoon, Ph.D. with former Rogel director Max Wicha, M.D., is in the competition for their work to develop a way to separate cancer cells out of blood samples taken from patients, so they can be tested for genetic signatures that could guide treatment.
Can one of them make it all the way, and defend the tournament title that Michigan scientists won last year? It all depends on how many members of the public vote for these true-blue entries!
A joint Engineering/Rogel Cancer Center team led by Eusik Yoon, Ph.D. with former Rogel director Max Wicha, M.D., is in the competition for their work to develop a way to separate cancer cells out of blood samples taken from patients, so they can be tested for genetic signatures that could guide treatment.
Can one of them make it all the way, and defend the tournament title that Michigan scientists won last year? It all depends on how many members of the public vote for these true-blue entries!



